The effects of platelet inhibitors on platelet uptake and restenosis after femoral angioplasty

International Angiology

Volumn 16, Issue 2, 1997, Pages 101-106

  Horrocks, M ^a   Horrocks, E H ^a   Murphy, P ^b   Lane, I F ^c   Ruttley, M S T ^c   Fligelstone, L J ^c   Watson, H R ^d  

^a ROYAL UNITED HOSPITAL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d BAYER PHARMA AG   (Germany)

Author keywords

Angioplasty, balloon; Arterial occlusive disease surgery; Aspirin therapeutic use; Blood platelets drug effects; Iloprost therapeutic use; Platelet aggregation inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ILOPROST; INDIUM 111;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; FLUSHING; HEADACHE; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; RESTENOSIS; SYMPTOM; THROMBOCYTE ACTIVATION; TIME; VOMITING;

AGED; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; ASPIRIN; CONSTRICTION, PATHOLOGIC; FEMALE; FEMORAL ARTERY; HUMANS; ILOPROST; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; POPLITEAL ARTERY; PROSPECTIVE STUDIES; RECURRENCE;

EID: 0030804798     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Gruntzig A, Kumpe DA. Technique of percutaneous transluminal angioplasty with the Gruntzig balloon catheter. Am J Radiol 1979;132:547-52.
2. Mosley JG, Gulati SM, Raphael M, Marston A. The role of percutaneous transluminal angioplasty for atherosclerotic disease of the lower extremities. Ann R Coll Surg Engl 1985;67:83-6.
3. Cole SEA, Baird RN, Horrocks M, Jeans WD. The role of balloon angioplasty in the management of lower limb ischemia. Eur J Vasc Surg 1987;1:61-5.
4. Johnston KW, Rae M, Hogg-Johnston SA, Colapinto RF, Walker PM, Baird RJ et al. Five year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg 1987;206(4):403-13.
5. Hewes RC, White RI, Murray RR, Kaufman SL, Chang R, Kadin S et al. Long-term results of superficial femoral artery angioplasty. Am J Roentgenol 1986;146:1025-9.
6. Murray RR, Hewes RC, White RI, Mitchell SE, Auster M, Chang R et al. Long segment femoropopliteal stenosis: is angioplasty a boon or bust? Radiology 1987; 162:473-6.
7. Poskitt KR, Harwood A, Scott DJA, Jeans WD, Baird RN, Horrocks M. Failure of peripheral arterial balloon angioplasty: does platelet deposition play a role? Eur J Vasc Surg 1991;5:541-7.
8. Vane JR. Prostacylin: a hormone with therapeutic potential. J Endocrinol 1982;95:3P-43P.
9. Schillinger E, Krais T, Lehmann M, Stock G. Iloprost. In: Scriabine A, editor. New cardiovascular drugs. New York: Raven Press, 1986:209-31.
10. Grant SM, Goa KL. Iloprost: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs 1992;43(6):889-924.
11. 111In)-labelled human platelets: optimal method. Clin Sci 1980:58:243-8.
12. Herrman J-PR, Hermans WRM, Vos J, Serruys PW. Pharmacological approaches to the prevention of restenosis following angioplasty. Drugs 1993;46(1):18-52.
13. Wilentz JR, Sanborn TA, Handenschild CC, Valeri CR, Ryan TJ, Faxon DP. Platelet accumulation in experimental angioplasty: time course and relation to vascular damage. Circulation 1987;75:636-42.
14. Study group on pharmacological treatment after PTA. Platelet inhibition with ASA/dipyridamole after percutaneous balloon angioplasty in patients with symptomatic lower limb arterial disease. A prospective double-blind study. Eur Vasc Surg 1994;8:83-8
15. Gershlick AH, Spriggins D, Davies SW, Syndercombe Court YD, Timmins J, Timmis AD et al. Failure of epoprostenol (prostacylin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial. Br Heart J 1994;71:7-15.
16. Raizner AE, Hollman J, Abukhalil J, Demke D. Ciprostene for restenosis revisited: qualitative analysis of angiograms. J Am Coll Cardiol 1993;21(2):321A.
17. Topol EJ, Califf RM, Weisman HF. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994;343:881-6.